Genomics and multi-omics companies develop technologies, services and analytical platforms that help researchers and clinicians understand biological systems at the DNA, RNA, protein and cellular level. The field underpins advances in precision medicine, drug discovery, diagnostics, agriculture and biotechnology.
This category includes companies working on:
Browse 190 UK genomics and multi-omics companies below.
Microplate consumables and instruments for life science laboratories
Porvair Sciences is a manufacturer of microplates, sample preparation consumables, and laboratory instruments for the life science and biotechnology industries. The company produces microplates across multiple formats and materials for applications spanning sample storage, solid phase extraction, cell culture, and…
Antibodies, proteins, and molecular reagents for life science research
ABclonal UK is the British subsidiary of a global life science tools and services group, supplying research reagents and custom development services to academic, diagnostic, and biopharmaceutical customers. Its catalogue spans recombinant and monoclonal antibodies, ELISA kits, active proteins, molecular enzymes, and…
Single-cell sequencing kits, instruments and genomic analysis services
Singleron Biotechnologies is a life science tools company providing single-cell sequencing technologies and genomic analysis services. Its portfolio includes microfluidic sample-processing kits, instruments, library preparation reagents and bioinformatics software for studying gene expression and molecular features in…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular disease, chronic kidney disease and non-alcoholic fatty liver disease. The company integrates multi-omics data with longitudinal clinical datasets…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
Life science campus co-locating early-stage companies with discovery research
Babraham Research Campus is a 430-acre life science campus south of Cambridge, home to over 60 companies and 300 academic researchers from the Babraham Institute. Campus companies have access to nine open-access scientific facilities operated by the Babraham Institute, including flow cytometry, genomics sequencing,…
Mechanobiology platform for target discovery and validation
Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery. The platform combines spatial multi-omics data from human tissue samples with mechanical tissue profiling and in silico tissue modelling to identify targets linked to changes in tissue…
Semiconductor sequencing platform for point-of-need diagnostics
DNA Electronics is a diagnostics company developing a semiconductor-based DNA sequencing platform for rapid, direct-from-specimen genomic analysis at the point of need. Its proprietary system integrates sample preparation and next-generation sequencing on a microchip, enabling clinical identification of bloodstream…
Genome-editing platform mapping cancer drug resistance and druggable vulnerabilities
BASE Rx is a Wellcome Sanger Institute spin-out applying genome-editing and DNA sequencing technologies to cancer drug discovery. The company maps single-base genetic variants to identify druggable vulnerabilities in cancer genes and predict the DNA changes that drive resistance to cancer therapies. BASE Rx aims to…
Precision therapeutics targeting fibrosis using multi-omics
Forth Therapeutics develops precision medicines intended to target the cellular mechanisms driving organ fibrosis. Its discovery platform combines single-cell and spatial genomics with patient-derived tissue data, including a large human liver disease dataset. These insights help identify disease-associated cells and…
Bioinformatics, software and compliance consultancy for biotech companies
Prismea is a provider of bioinformatics, software and cloud consultancy services for biotechnology companies. The company supports biotech clients with data analysis across genomics, imaging, spectroscopy, epidemiology and metabolomics, alongside custom software development, cloud infrastructure management and…
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and fragmentomics with advanced bioinformatics and machine learning to identify disease-associated DNA markers from blood and other biological sources.…
Molecular biology enzymes and UK scientific reagent support
New England Biolabs (UK) is the British sales and technical-support subsidiary of New England Biolabs, supplying molecular biology reagents to research laboratories. Its catalogue includes restriction enzymes, DNA and RNA modifying enzymes, nucleic acid purification products, PCR reagents and sequencing library…
Non-CRISPR RNA-guided gene editing and modulation platform
Pencil Biosciences is a gene editing company developing a fully synthetic, RNA-guided genome modulation platform as an alternative to CRISPR-based technologies. The system is modular in design, significantly smaller than Cas-based tools, and intended to enable precise gene knock-ins without DNA cleavage. Primary…
Custom qPCR, digital PCR and amplicon sequencing reagents
SHARD DIAGNOSTICS is a Nottingham molecular diagnostics company developing and manufacturing PCR assay reagents and bespoke molecular testing kits. Its technologies support quantitative and digital PCR, multiplex detection and amplicon sequencing, including inhibitor-tolerant and lyophilised formulations. Applications…
Novel methylation amplification platform for clinical genomic diagnostics
Syndex Bio is a Cambridge-based biotechnology company developing a proprietary platform technology that enables amplification of DNA methylation for the first time. Unlike conventional PCR, which cannot preserve 5-methylcytosine signals, mcPCR copies both the four-base DNA code and its methylation patterns from…
ADC pipeline targeting mutant stem cells in blood cancers
Alethio Therapeutics Limited is a preclinical-stage biotechnology company developing antibody-drug conjugates for myeloproliferative neoplasms, a group of chronic blood cancers. Its pipeline targets the mutant stem and progenitor cells that drive disease progression and fibrosis, with the aim of modifying rather than…
Biomedical software development for genomics and medical imaging
Phenopolis is a London scientific software company developing applications and analysis pipelines for biomedical research and healthcare. Its services cover genetics, DNA methylation analysis, medical imaging, large-scale data processing and secure handling of patient information. It builds cloud and on-premises…
Molecular biology reagents and kits for DNA and RNA research
Microzone is a UK manufacturer of molecular biology reagents and kits for DNA and RNA research and diagnostics. The company produces PCR and qPCR mastermixes, direct to PCR sample lysis buffers, extraction free DNA and RNA clean up products, and magnetic bead based extraction kits. Microzone products are cited in peer…
Large-scale genomics research institute advancing human and pathogen biology
The Wellcome Sanger Institute is a genomics research institute on the Wellcome Genome Campus in Hinxton, funded by Wellcome. It made the largest single contribution to the Human Genome Project and has since expanded across cancer genomics, cellular genetics, infectious disease and parasitology. Research programmes…